Back to Search
SRIYESH KRISHNAN, MD
MD
Diagnostic Radiology Physician
NPI: 1699804674IndividualAccepts Medicare
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
201100257(NC)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
DUKE UNIVERSITY SCHOOL OF MEDICINE
Class of 2006
Research & Publications (20)
The role of adjuvant radiation therapy in nonmetastatic gastric cancer: an evolving paradigm.
PMID 19343136·Gastrointest Cancer Res·2009
8-other
Prevalence and significance of cardiometabolic risk factors in children with type 1 diabetes.
PMID 19245517·J Cardiometab Syndr·2009
6-review
Metabolism, distribution and elimination of lisdexamfetamine dimesylate: open-label, single-centre, phase I study in healthy adult volunteers.
PMID 18991468·Clin Drug Investig·2008
3-trial
Relative bioavailability of lisdexamfetamine 70-mg capsules in fasted and fed healthy adult volunteers and in solution: a single-dose, crossover pharmacokinetic study.
PMID 18285619·J Clin Pharmacol·2008
2-rct
Poverty, gender inequities, and women's risk of human immunodeficiency virus/AIDS.
PMID 17954681·Ann N Y Acad Sci·2008
8-other
Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater.
PMID 17980502·Int J Radiat Oncol Biol Phys·2008
8-other
Synergy of gatifloxacin with cefoperazone and cefoperazone-sulbactam against resistant strains of Pseudomonas aeruginosa.
PMID 19018022·J Med Microbiol·2008
8-other
Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy.
PMID 17538975·Cancer·2007
8-other
Daily targeting of liver tumors: screening patients with a mock treatment and using a combination of internal and external fiducials for image-guided respiratory-gated radiotherapy.
PMID 18196785·Med Phys·2007
8-other
Toxicity profile of lisdexamfetamine dimesylate in three independent rat toxicology studies.
PMID 17845504·Basic Clin Pharmacol Toxicol·2007
7-preclinical
Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177.
PMID 16626884·Int J Radiat Oncol Biol Phys·2006
3-trial
Surfaces of fluorinated pyridinium block copolymers with enhanced antibacterial activity.
PMID 17154613·Langmuir·2006
8-other
Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases.
PMID 17148992·Am J Clin Oncol·2006
8-other
Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation.
PMID 17083124·Cancer·2006
8-other
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.
PMID 17011451·Int J Radiat Oncol Biol Phys·2006
3-trial
Neuropsychological functions in progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.
PMID 16936386·Neurol India·2006
4-observational
Anti-biofouling properties of comblike block copolymers with amphiphilic side chains.
PMID 16700597·Langmuir·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1331 N ELM ST STE 200
GREENSBORO, NC 27401 - Phone
- (336) 274-6682
Quick Facts
- NPI
- 1699804674
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 20
- Publications
- 20
Are you this provider?
Claim Your Profile